Published on Canadian Women's Health Network (http://www.cwhn.ca)

Home > Disease mongering in drug promotion: do governments have a regulatory role?

Disease mongering in drug promotion: do governments have a regulatory role?

Tagged :
Print [6]
Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Paper
Online
Author: 
Barbara Mintzes
Publisher: 
PLoS Medicine
Publication Date: 
2006
Publication Place: 
San Francisco, CA

Examines activities financed by drug companies to promote sales by expanding the pool of patients potentially treated by their products, when no benefit in terms of reduced morbidity is likely.

Available From: 
Public Library of Science [7]
ISBN/ISSN: 
ISSN 15491277 (print)
ISSN 15491676 (online)
URLs: 
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030198 [8]
Notes: 
Includes bibliographical references.

Subscribe / S'abonner aux nouvelles

Email: *
Brigit's Notes / Bloc-notes de Brigit
Event Notices / Avis
Source URL: http://www.cwhn.ca/en/node/27631

Links:
[1] http://www.cwhn.ca/en/taxonomy/term/3568
[2] http://www.cwhn.ca/en/taxonomy/term/3569
[3] http://www.cwhn.ca/en/taxonomy/term/3850
[4] http://www.cwhn.ca/en/taxonomy/term/4151
[5] http://www.cwhn.ca/en/taxonomy/term/4147
[6] http://www.cwhn.ca/print/27631
[7] http://www.cwhn.ca/en/node/20182
[8] http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030198